Table 2 Patient characteristics (n = 122)
Patient parameter | Value |
|---|---|
Median age (years; range) | 71.5 (50.9–83.3) |
Gleason score, n (%) | |
Low risk (2–6) | 50 (41%) |
Intermediate risk (7) | 48 (39.3%) |
High risk (8–10) | 23 (18.9%) |
Serum PSA (ng/ml), n (%) | |
Low risk (<10) | 52 (42.6%) |
Intermediate risk (10–20) | 38 (31.1%) |
High risk (>20) | 32 (26.2%) |
Initial tumor stage (clinical examination and CT), n (%) | |
Low risk (T1–2a) | 53 (43.4%) |
Intermediate risk (T2b-c) | 44 (36.1%) |
High risk: extracapsular extension (T3a) | 21 (17.2%) |
High risk: seminal vesicle infiltration (T3b) | 4 (3.3%) |